nodes	percent_of_prediction	percent_of_DWPC	metapath
Pomalidomide—TNF—Parkinson's disease	0.618	0.712	CbGaD
Pomalidomide—ABCB1—Parkinson's disease	0.25	0.288	CbGaD
Pomalidomide—Thalidomide—TNF—Parkinson's disease	0.0024	0.409	CrCbGaD
Pomalidomide—Thalidomide—CYP2E1—Parkinson's disease	0.00185	0.315	CrCbGaD
Pomalidomide—Lenalidomide—ABCB1—Parkinson's disease	0.00162	0.276	CrCbGaD
Pomalidomide—CRBN—embryo—Parkinson's disease	0.00106	0.11	CbGeAlD
Pomalidomide—CRBN—forebrain—Parkinson's disease	0.000937	0.097	CbGeAlD
Pomalidomide—CRBN—medulla oblongata—Parkinson's disease	0.000677	0.0701	CbGeAlD
Pomalidomide—CRBN—midbrain—Parkinson's disease	0.000619	0.0641	CbGeAlD
Pomalidomide—CRBN—spinal cord—Parkinson's disease	0.000604	0.0625	CbGeAlD
Pomalidomide—CRBN—head—Parkinson's disease	0.000537	0.0555	CbGeAlD
Pomalidomide—CRBN—nervous system—Parkinson's disease	0.000509	0.0527	CbGeAlD
Pomalidomide—CRBN—central nervous system—Parkinson's disease	0.00049	0.0507	CbGeAlD
Pomalidomide—CRBN—cerebellum—Parkinson's disease	0.000479	0.0496	CbGeAlD
Pomalidomide—CRBN—brain—Parkinson's disease	0.000389	0.0403	CbGeAlD
Pomalidomide—PTGS2—embryo—Parkinson's disease	0.000289	0.0299	CbGeAlD
Pomalidomide—PTGS2—forebrain—Parkinson's disease	0.000255	0.0264	CbGeAlD
Pomalidomide—PTGS2—cardiovascular system—Parkinson's disease	0.000216	0.0223	CbGeAlD
Pomalidomide—PTGS2—medulla oblongata—Parkinson's disease	0.000184	0.0191	CbGeAlD
Pomalidomide—ABCB1—embryo—Parkinson's disease	0.000178	0.0185	CbGeAlD
Pomalidomide—PTGS2—midbrain—Parkinson's disease	0.000169	0.0174	CbGeAlD
Pomalidomide—PTGS2—spinal cord—Parkinson's disease	0.000164	0.017	CbGeAlD
Pomalidomide—ABCB1—forebrain—Parkinson's disease	0.000158	0.0163	CbGeAlD
Pomalidomide—TNF—MicroRNAs in cardiomyocyte hypertrophy—MAPK8—Parkinson's disease	0.000148	0.00127	CbGpPWpGaD
Pomalidomide—PTGS2—head—Parkinson's disease	0.000146	0.0151	CbGeAlD
Pomalidomide—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2E1—Parkinson's disease	0.000144	0.00123	CbGpPWpGaD
Pomalidomide—CYP3A4—Oxidation by Cytochrome P450—CYP2E1—Parkinson's disease	0.000142	0.00121	CbGpPWpGaD
Pomalidomide—TNF—Vitamin B12 Metabolism—IL6—Parkinson's disease	0.000141	0.0012	CbGpPWpGaD
Pomalidomide—PTGS2—nervous system—Parkinson's disease	0.000139	0.0143	CbGeAlD
Pomalidomide—TNF—Toll-like Receptor Signaling Pathway—IL1B—Parkinson's disease	0.000138	0.00118	CbGpPWpGaD
Pomalidomide—TNF—TNF alpha Signaling Pathway—MAPK8—Parkinson's disease	0.000138	0.00118	CbGpPWpGaD
Pomalidomide—ABCB1—cardiovascular system—Parkinson's disease	0.000133	0.0138	CbGeAlD
Pomalidomide—PTGS2—central nervous system—Parkinson's disease	0.000133	0.0138	CbGeAlD
Pomalidomide—CYP1A2—Biological oxidations—GSTA4—Parkinson's disease	0.000132	0.00113	CbGpPWpGaD
Pomalidomide—ABCB1—Allograft Rejection—FASLG—Parkinson's disease	0.000132	0.00113	CbGpPWpGaD
Pomalidomide—CYP1A2—Metapathway biotransformation—GSTA4—Parkinson's disease	0.000131	0.00111	CbGpPWpGaD
Pomalidomide—PTGS2—cerebellum—Parkinson's disease	0.00013	0.0135	CbGeAlD
Pomalidomide—PTGS2—Metabolism of lipids and lipoproteins—GBA—Parkinson's disease	0.00013	0.00111	CbGpPWpGaD
Pomalidomide—PTGS2—Selenium Micronutrient Network—INS—Parkinson's disease	0.000129	0.0011	CbGpPWpGaD
Pomalidomide—CYP3A4—Phase 1 - Functionalization of compounds—CYP2D6—Parkinson's disease	0.000127	0.00109	CbGpPWpGaD
Pomalidomide—TNF—Toll-like Receptor Signaling Pathway—MAPK8—Parkinson's disease	0.000127	0.00108	CbGpPWpGaD
Pomalidomide—CYP1A2—Phase 1 - Functionalization of compounds—MAOA—Parkinson's disease	0.000124	0.00106	CbGpPWpGaD
Pomalidomide—ABCB1—Integrated Pancreatic Cancer Pathway—MAPT—Parkinson's disease	0.000123	0.00105	CbGpPWpGaD
Pomalidomide—TNF—Spinal Cord Injury—IL1B—Parkinson's disease	0.000123	0.00105	CbGpPWpGaD
Pomalidomide—TNF—Spinal Cord Injury—CASP3—Parkinson's disease	0.000123	0.00105	CbGpPWpGaD
Pomalidomide—CYP3A4—nervous system—Parkinson's disease	0.000121	0.0125	CbGeAlD
Pomalidomide—CYP1A2—Biological oxidations—MAOB—Parkinson's disease	0.000118	0.00101	CbGpPWpGaD
Pomalidomide—PTGS2—Aryl Hydrocarbon Receptor—TNF—Parkinson's disease	0.000117	0.001	CbGpPWpGaD
Pomalidomide—CYP3A4—central nervous system—Parkinson's disease	0.000117	0.0121	CbGeAlD
Pomalidomide—CYP3A4—Phase 1 - Functionalization of compounds—CYP2E1—Parkinson's disease	0.000117	0.000995	CbGpPWpGaD
Pomalidomide—TNF—Folate Metabolism—IL6—Parkinson's disease	0.000115	0.00098	CbGpPWpGaD
Pomalidomide—ABCB1—medulla oblongata—Parkinson's disease	0.000114	0.0118	CbGeAlD
Pomalidomide—CYP1A2—Phase II conjugation—COMT—Parkinson's disease	0.000114	0.00097	CbGpPWpGaD
Pomalidomide—CYP1A2—Phase II conjugation—GSTP1—Parkinson's disease	0.000113	0.000965	CbGpPWpGaD
Pomalidomide—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—TNF—Parkinson's disease	0.00011	0.000938	CbGpPWpGaD
Pomalidomide—TNF—Regulation of toll-like receptor signaling pathway—IL1B—Parkinson's disease	0.000108	0.000922	CbGpPWpGaD
Pomalidomide—TNF—Developmental Biology—HSPA8—Parkinson's disease	0.000106	0.000907	CbGpPWpGaD
Pomalidomide—PTGS2—brain—Parkinson's disease	0.000106	0.011	CbGeAlD
Pomalidomide—PTGS2—Integrated Pancreatic Cancer Pathway—ABL1—Parkinson's disease	0.000105	0.000897	CbGpPWpGaD
Pomalidomide—ABCB1—midbrain—Parkinson's disease	0.000104	0.0108	CbGeAlD
Pomalidomide—CYP1A2—Phase II conjugation—GSTM1—Parkinson's disease	0.000104	0.000887	CbGpPWpGaD
Pomalidomide—PTGS2—Integrated Pancreatic Cancer Pathway—BDNF—Parkinson's disease	0.000103	0.000884	CbGpPWpGaD
Pomalidomide—ABCB1—Transmembrane transport of small molecules—TRPM7—Parkinson's disease	0.000103	0.000877	CbGpPWpGaD
Pomalidomide—ABCB1—Transmembrane transport of small molecules—ATP1A3—Parkinson's disease	0.000103	0.000877	CbGpPWpGaD
Pomalidomide—CYP3A4—Biological oxidations—GSTA4—Parkinson's disease	0.000102	0.000872	CbGpPWpGaD
Pomalidomide—PTGS2—Integrated Pancreatic Cancer Pathway—ABCB1—Parkinson's disease	0.000102	0.000869	CbGpPWpGaD
Pomalidomide—ABCB1—spinal cord—Parkinson's disease	0.000102	0.0105	CbGeAlD
Pomalidomide—CYP3A4—Metapathway biotransformation—GSTA4—Parkinson's disease	0.000101	0.00086	CbGpPWpGaD
Pomalidomide—TNF—Developmental Biology—DLG4—Parkinson's disease	9.97e-05	0.000851	CbGpPWpGaD
Pomalidomide—TNF—Regulation of toll-like receptor signaling pathway—MAPK8—Parkinson's disease	9.91e-05	0.000846	CbGpPWpGaD
Pomalidomide—TNF—Apoptosis—CASP3—Parkinson's disease	9.88e-05	0.000843	CbGpPWpGaD
Pomalidomide—TNF—SIDS Susceptibility Pathways—IL1B—Parkinson's disease	9.85e-05	0.000841	CbGpPWpGaD
Pomalidomide—TNF—SIDS Susceptibility Pathways—CASP3—Parkinson's disease	9.83e-05	0.000839	CbGpPWpGaD
Pomalidomide—PTGS2—Disease—VPS35—Parkinson's disease	9.78e-05	0.000835	CbGpPWpGaD
Pomalidomide—TNF—Developmental Biology—GRIN2B—Parkinson's disease	9.74e-05	0.000832	CbGpPWpGaD
Pomalidomide—PTGS2—Selenium Micronutrient Network—IL1B—Parkinson's disease	9.63e-05	0.000822	CbGpPWpGaD
Pomalidomide—CYP3A4—Phase 1 - Functionalization of compounds—MAOA—Parkinson's disease	9.59e-05	0.000819	CbGpPWpGaD
Pomalidomide—TNF—MAPK Signaling Pathway—IL1B—Parkinson's disease	9.28e-05	0.000793	CbGpPWpGaD
Pomalidomide—TNF—MAPK Signaling Pathway—CASP3—Parkinson's disease	9.26e-05	0.000791	CbGpPWpGaD
Pomalidomide—PTGS2—Integrated Pancreatic Cancer Pathway—FASLG—Parkinson's disease	9.18e-05	0.000784	CbGpPWpGaD
Pomalidomide—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL1B—Parkinson's disease	9.16e-05	0.000782	CbGpPWpGaD
Pomalidomide—TNF—Selenium Micronutrient Network—IL6—Parkinson's disease	9.12e-05	0.000779	CbGpPWpGaD
Pomalidomide—CYP3A4—Biological oxidations—MAOB—Parkinson's disease	9.11e-05	0.000778	CbGpPWpGaD
Pomalidomide—PTGS2—Disease—MCCC1—Parkinson's disease	9.09e-05	0.000777	CbGpPWpGaD
Pomalidomide—TNF—Apoptosis—MAPK8—Parkinson's disease	9.08e-05	0.000775	CbGpPWpGaD
Pomalidomide—ABCB1—head—Parkinson's disease	9.04e-05	0.00936	CbGeAlD
Pomalidomide—TNF—TNF alpha Signaling Pathway—IL6—Parkinson's disease	8.8e-05	0.000751	CbGpPWpGaD
Pomalidomide—CYP1A2—Biological oxidations—CYP2D6—Parkinson's disease	8.77e-05	0.000749	CbGpPWpGaD
Pomalidomide—CYP1A2—Metapathway biotransformation—CYP2D6—Parkinson's disease	8.65e-05	0.000739	CbGpPWpGaD
Pomalidomide—ABCB1—nervous system—Parkinson's disease	8.57e-05	0.00887	CbGeAlD
Pomalidomide—PTGS2—Disease—TALDO1—Parkinson's disease	8.55e-05	0.00073	CbGpPWpGaD
Pomalidomide—PTGS2—Disease—OMD—Parkinson's disease	8.55e-05	0.00073	CbGpPWpGaD
Pomalidomide—TNF—MAPK Signaling Pathway—MAPK8—Parkinson's disease	8.51e-05	0.000727	CbGpPWpGaD
Pomalidomide—TNF—Integrated Pancreatic Cancer Pathway—CASP3—Parkinson's disease	8.36e-05	0.000714	CbGpPWpGaD
Pomalidomide—ABCB1—central nervous system—Parkinson's disease	8.25e-05	0.00854	CbGeAlD
Pomalidomide—TNF—Toll-like Receptor Signaling Pathway—IL6—Parkinson's disease	8.1e-05	0.000692	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism of lipids and lipoproteins—PLA2G6—Parkinson's disease	8.09e-05	0.000691	CbGpPWpGaD
Pomalidomide—ABCB1—cerebellum—Parkinson's disease	8.06e-05	0.00835	CbGeAlD
Pomalidomide—CYP1A2—Biological oxidations—CYP2E1—Parkinson's disease	8.02e-05	0.000685	CbGpPWpGaD
Pomalidomide—TNF—Developmental Biology—ABL1—Parkinson's disease	7.94e-05	0.000678	CbGpPWpGaD
Pomalidomide—CYP1A2—Metapathway biotransformation—CYP2E1—Parkinson's disease	7.91e-05	0.000675	CbGpPWpGaD
Pomalidomide—TNF—Integrated Pancreatic Cancer Pathway—MAPK8—Parkinson's disease	7.68e-05	0.000656	CbGpPWpGaD
Pomalidomide—PTGS2—Spinal Cord Injury—IL1B—Parkinson's disease	7.62e-05	0.00065	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism—ND3—Parkinson's disease	7.62e-05	0.00065	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism—MCCC1—Parkinson's disease	7.62e-05	0.00065	CbGpPWpGaD
Pomalidomide—PTGS2—Spinal Cord Injury—CASP3—Parkinson's disease	7.6e-05	0.000649	CbGpPWpGaD
Pomalidomide—ABCB1—Integrated Pancreatic Cancer Pathway—ABL1—Parkinson's disease	7.45e-05	0.000636	CbGpPWpGaD
Pomalidomide—ABCB1—Allograft Rejection—IL1B—Parkinson's disease	7.44e-05	0.000635	CbGpPWpGaD
Pomalidomide—ABCB1—Allograft Rejection—CASP3—Parkinson's disease	7.43e-05	0.000634	CbGpPWpGaD
Pomalidomide—ABCB1—Integrated Pancreatic Cancer Pathway—BDNF—Parkinson's disease	7.33e-05	0.000626	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism of lipids and lipoproteins—GBA—Parkinson's disease	7.33e-05	0.000626	CbGpPWpGaD
Pomalidomide—TNF—Spinal Cord Injury—IL6—Parkinson's disease	7.21e-05	0.000616	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism—OMD—Parkinson's disease	7.16e-05	0.000611	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism—TALDO1—Parkinson's disease	7.16e-05	0.000611	CbGpPWpGaD
Pomalidomide—PTGS2—Selenium Micronutrient Network—TNF—Parkinson's disease	6.99e-05	0.000597	CbGpPWpGaD
Pomalidomide—PTGS2—Disease—TAF1—Parkinson's disease	6.89e-05	0.000588	CbGpPWpGaD
Pomalidomide—PTGS2—Disease—FBP1—Parkinson's disease	6.89e-05	0.000588	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism—NDUFB11—Parkinson's disease	6.79e-05	0.00058	CbGpPWpGaD
Pomalidomide—CYP3A4—Biological oxidations—CYP2D6—Parkinson's disease	6.77e-05	0.000578	CbGpPWpGaD
Pomalidomide—CYP3A4—Metapathway biotransformation—CYP2D6—Parkinson's disease	6.67e-05	0.00057	CbGpPWpGaD
Pomalidomide—TNF—Adipogenesis—IL6—Parkinson's disease	6.67e-05	0.00057	CbGpPWpGaD
Pomalidomide—CYP1A2—Biological oxidations—COMT—Parkinson's disease	6.65e-05	0.000568	CbGpPWpGaD
Pomalidomide—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—Parkinson's disease	6.64e-05	0.000567	CbGpPWpGaD
Pomalidomide—CYP1A2—Aryl Hydrocarbon Receptor—TNF—Parkinson's disease	6.64e-05	0.000567	CbGpPWpGaD
Pomalidomide—CYP1A2—Biological oxidations—GSTP1—Parkinson's disease	6.61e-05	0.000565	CbGpPWpGaD
Pomalidomide—CYP1A2—Biological oxidations—MAOA—Parkinson's disease	6.6e-05	0.000564	CbGpPWpGaD
Pomalidomide—CYP1A2—Metapathway biotransformation—COMT—Parkinson's disease	6.55e-05	0.00056	CbGpPWpGaD
Pomalidomide—ABCB1—brain—Parkinson's disease	6.55e-05	0.00678	CbGeAlD
Pomalidomide—CYP1A2—Metapathway biotransformation—GSTP1—Parkinson's disease	6.52e-05	0.000557	CbGpPWpGaD
Pomalidomide—ABCB1—Integrated Pancreatic Cancer Pathway—FASLG—Parkinson's disease	6.51e-05	0.000556	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism—GCH1—Parkinson's disease	6.48e-05	0.000553	CbGpPWpGaD
Pomalidomide—TNF—Regulation of toll-like receptor signaling pathway—IL6—Parkinson's disease	6.33e-05	0.00054	CbGpPWpGaD
Pomalidomide—CYP3A4—Biological oxidations—CYP2E1—Parkinson's disease	6.19e-05	0.000529	CbGpPWpGaD
Pomalidomide—CYP3A4—Metapathway biotransformation—CYP2E1—Parkinson's disease	6.1e-05	0.000521	CbGpPWpGaD
Pomalidomide—CYP1A2—Biological oxidations—GSTM1—Parkinson's disease	6.08e-05	0.000519	CbGpPWpGaD
Pomalidomide—CYP1A2—Metapathway biotransformation—GSTM1—Parkinson's disease	5.99e-05	0.000512	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism of lipids and lipoproteins—CTGF—Parkinson's disease	5.84e-05	0.000499	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism—FBP1—Parkinson's disease	5.77e-05	0.000493	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism—GBA—Parkinson's disease	5.77e-05	0.000493	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism—DBH—Parkinson's disease	5.77e-05	0.000493	CbGpPWpGaD
Pomalidomide—TNF—SIDS Susceptibility Pathways—IL6—Parkinson's disease	5.77e-05	0.000493	CbGpPWpGaD
Pomalidomide—PTGS2—Selenium Micronutrient Network—IL6—Parkinson's disease	5.64e-05	0.000482	CbGpPWpGaD
Pomalidomide—PTGS2—Spinal Cord Injury—TNF—Parkinson's disease	5.53e-05	0.000472	CbGpPWpGaD
Pomalidomide—PTGS2—Disease—RPL6—Parkinson's disease	5.51e-05	0.00047	CbGpPWpGaD
Pomalidomide—PTGS2—Disease—SNCA—Parkinson's disease	5.51e-05	0.00047	CbGpPWpGaD
Pomalidomide—ABCB1—Transmembrane transport of small molecules—SLC18A2—Parkinson's disease	5.45e-05	0.000466	CbGpPWpGaD
Pomalidomide—ABCB1—Allograft Rejection—TNF—Parkinson's disease	5.4e-05	0.000461	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—MCCC1—Parkinson's disease	5.4e-05	0.000461	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—ND3—Parkinson's disease	5.4e-05	0.000461	CbGpPWpGaD
Pomalidomide—TNF—Developmental Biology—INS—Parkinson's disease	5.25e-05	0.000448	CbGpPWpGaD
Pomalidomide—PTGS2—Integrated Pancreatic Cancer Pathway—CASP3—Parkinson's disease	5.17e-05	0.000441	CbGpPWpGaD
Pomalidomide—CYP3A4—Biological oxidations—COMT—Parkinson's disease	5.13e-05	0.000438	CbGpPWpGaD
Pomalidomide—CYP3A4—Biological oxidations—GSTP1—Parkinson's disease	5.1e-05	0.000436	CbGpPWpGaD
Pomalidomide—CYP3A4—Biological oxidations—MAOA—Parkinson's disease	5.09e-05	0.000435	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—TALDO1—Parkinson's disease	5.08e-05	0.000433	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—OMD—Parkinson's disease	5.08e-05	0.000433	CbGpPWpGaD
Pomalidomide—CYP3A4—Metapathway biotransformation—COMT—Parkinson's disease	5.06e-05	0.000432	CbGpPWpGaD
Pomalidomide—CYP3A4—Metapathway biotransformation—GSTP1—Parkinson's disease	5.03e-05	0.00043	CbGpPWpGaD
Pomalidomide—ABCB1—Transmembrane transport of small molecules—CP—Parkinson's disease	5.02e-05	0.000428	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—NDUFB11—Parkinson's disease	4.81e-05	0.000411	CbGpPWpGaD
Pomalidomide—PTGS2—Integrated Pancreatic Cancer Pathway—MAPK8—Parkinson's disease	4.75e-05	0.000406	CbGpPWpGaD
Pomalidomide—CYP3A4—Biological oxidations—GSTM1—Parkinson's disease	4.69e-05	0.000401	CbGpPWpGaD
Pomalidomide—CYP3A4—Metapathway biotransformation—GSTM1—Parkinson's disease	4.63e-05	0.000395	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—GCH1—Parkinson's disease	4.59e-05	0.000392	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism of lipids and lipoproteins—PLA2G6—Parkinson's disease	4.58e-05	0.000391	CbGpPWpGaD
Pomalidomide—PTGS2—Spinal Cord Injury—IL6—Parkinson's disease	4.46e-05	0.000381	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—MCCC1—Parkinson's disease	4.31e-05	0.000368	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—ND3—Parkinson's disease	4.31e-05	0.000368	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism—DDC—Parkinson's disease	4.24e-05	0.000362	CbGpPWpGaD
Pomalidomide—PTGS2—Disease—RPL23A—Parkinson's disease	4.18e-05	0.000357	CbGpPWpGaD
Pomalidomide—PTGS2—Disease—RPL14—Parkinson's disease	4.18e-05	0.000357	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—GBA—Parkinson's disease	4.09e-05	0.000349	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—DBH—Parkinson's disease	4.09e-05	0.000349	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—FBP1—Parkinson's disease	4.09e-05	0.000349	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—OMD—Parkinson's disease	4.05e-05	0.000346	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—TALDO1—Parkinson's disease	4.05e-05	0.000346	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism—GSTA4—Parkinson's disease	4e-05	0.000342	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism of lipids and lipoproteins—GPX1—Parkinson's disease	3.95e-05	0.000337	CbGpPWpGaD
Pomalidomide—PTGS2—Disease—RPS8—Parkinson's disease	3.89e-05	0.000333	CbGpPWpGaD
Pomalidomide—PTGS2—Disease—FGF20—Parkinson's disease	3.89e-05	0.000333	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—NDUFB11—Parkinson's disease	3.84e-05	0.000328	CbGpPWpGaD
Pomalidomide—PTGS2—Integrated Pancreatic Cancer Pathway—TNF—Parkinson's disease	3.76e-05	0.000321	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—GCH1—Parkinson's disease	3.66e-05	0.000313	CbGpPWpGaD
Pomalidomide—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—Parkinson's disease	3.66e-05	0.000313	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism—PLA2G6—Parkinson's disease	3.6e-05	0.000308	CbGpPWpGaD
Pomalidomide—ABCB1—Transmembrane transport of small molecules—SLC6A3—Parkinson's disease	3.57e-05	0.000305	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism—MAOB—Parkinson's disease	3.57e-05	0.000304	CbGpPWpGaD
Pomalidomide—ABCB1—Transmembrane transport of small molecules—CYCS—Parkinson's disease	3.43e-05	0.000293	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism of lipids and lipoproteins—APOE—Parkinson's disease	3.39e-05	0.00029	CbGpPWpGaD
Pomalidomide—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK8—Parkinson's disease	3.37e-05	0.000288	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—ND3—Parkinson's disease	3.33e-05	0.000284	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—MCCC1—Parkinson's disease	3.33e-05	0.000284	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism of lipids and lipoproteins—CTGF—Parkinson's disease	3.31e-05	0.000282	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—GBA—Parkinson's disease	3.27e-05	0.000279	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—DBH—Parkinson's disease	3.27e-05	0.000279	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—FBP1—Parkinson's disease	3.27e-05	0.000279	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—OMD—Parkinson's disease	3.13e-05	0.000267	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—TALDO1—Parkinson's disease	3.13e-05	0.000267	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—DDC—Parkinson's disease	3e-05	0.000256	CbGpPWpGaD
Pomalidomide—ABCB1—Transmembrane transport of small molecules—HMOX1—Parkinson's disease	2.98e-05	0.000255	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—NDUFB11—Parkinson's disease	2.96e-05	0.000253	CbGpPWpGaD
Pomalidomide—PTGS2—Disease—ADRBK1—Parkinson's disease	2.86e-05	0.000244	CbGpPWpGaD
Pomalidomide—PTGS2—Disease—HSPA1A—Parkinson's disease	2.84e-05	0.000243	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—GSTA4—Parkinson's disease	2.84e-05	0.000242	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—GCH1—Parkinson's disease	2.83e-05	0.000241	CbGpPWpGaD
Pomalidomide—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—Parkinson's disease	2.66e-05	0.000228	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism—CYP2D6—Parkinson's disease	2.65e-05	0.000226	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism—CTGF—Parkinson's disease	2.6e-05	0.000222	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—PLA2G6—Parkinson's disease	2.55e-05	0.000218	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—MAOB—Parkinson's disease	2.53e-05	0.000216	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—FBP1—Parkinson's disease	2.52e-05	0.000215	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—DBH—Parkinson's disease	2.52e-05	0.000215	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—GBA—Parkinson's disease	2.52e-05	0.000215	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism—CYP2E1—Parkinson's disease	2.42e-05	0.000207	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—DDC—Parkinson's disease	2.4e-05	0.000205	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism—NQO1—Parkinson's disease	2.4e-05	0.000205	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism—TH—Parkinson's disease	2.36e-05	0.000202	CbGpPWpGaD
Pomalidomide—TNF—Developmental Biology—IL6—Parkinson's disease	2.29e-05	0.000196	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism—CYCS—Parkinson's disease	2.27e-05	0.000194	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—GSTA4—Parkinson's disease	2.26e-05	0.000193	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism of lipids and lipoproteins—GPX1—Parkinson's disease	2.24e-05	0.000191	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—PLA2G6—Parkinson's disease	2.04e-05	0.000174	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—MAOB—Parkinson's disease	2.02e-05	0.000172	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism—COMT—Parkinson's disease	2.01e-05	0.000172	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism—GSTP1—Parkinson's disease	2e-05	0.000171	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism—MAOA—Parkinson's disease	1.99e-05	0.00017	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism—HMOX1—Parkinson's disease	1.97e-05	0.000168	CbGpPWpGaD
Pomalidomide—PTGS2—Disease—MTHFR—Parkinson's disease	1.94e-05	0.000166	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism of lipids and lipoproteins—APOE—Parkinson's disease	1.92e-05	0.000164	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism—ABCB1—Parkinson's disease	1.89e-05	0.000162	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—CYP2D6—Parkinson's disease	1.88e-05	0.00016	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—DDC—Parkinson's disease	1.85e-05	0.000158	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—CTGF—Parkinson's disease	1.84e-05	0.000157	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism—GSTM1—Parkinson's disease	1.84e-05	0.000157	CbGpPWpGaD
Pomalidomide—PTGS2—Disease—APOE—Parkinson's disease	1.8e-05	0.000154	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism—GPX1—Parkinson's disease	1.76e-05	0.00015	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—GSTA4—Parkinson's disease	1.75e-05	0.000149	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—CYP2E1—Parkinson's disease	1.72e-05	0.000147	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—NQO1—Parkinson's disease	1.7e-05	0.000145	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—TH—Parkinson's disease	1.67e-05	0.000143	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism—MTHFR—Parkinson's disease	1.62e-05	0.000139	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—CYCS—Parkinson's disease	1.61e-05	0.000137	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—PLA2G6—Parkinson's disease	1.57e-05	0.000134	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—MAOB—Parkinson's disease	1.56e-05	0.000133	CbGpPWpGaD
Pomalidomide—PTGS2—Disease—INS—Parkinson's disease	1.54e-05	0.000132	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism—APOE—Parkinson's disease	1.51e-05	0.000129	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—CYP2D6—Parkinson's disease	1.5e-05	0.000128	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—CTGF—Parkinson's disease	1.47e-05	0.000126	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—COMT—Parkinson's disease	1.42e-05	0.000122	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—GSTP1—Parkinson's disease	1.42e-05	0.000121	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—MAOA—Parkinson's disease	1.41e-05	0.000121	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—HMOX1—Parkinson's disease	1.4e-05	0.000119	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—CYP2E1—Parkinson's disease	1.37e-05	0.000117	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—NQO1—Parkinson's disease	1.36e-05	0.000116	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—TH—Parkinson's disease	1.34e-05	0.000114	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—GSTM1—Parkinson's disease	1.3e-05	0.000111	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism—INS—Parkinson's disease	1.29e-05	0.00011	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—CYCS—Parkinson's disease	1.28e-05	0.00011	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—GPX1—Parkinson's disease	1.25e-05	0.000106	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—CYP2D6—Parkinson's disease	1.16e-05	9.88e-05	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—MTHFR—Parkinson's disease	1.15e-05	9.83e-05	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—COMT—Parkinson's disease	1.14e-05	9.71e-05	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—CTGF—Parkinson's disease	1.14e-05	9.7e-05	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—GSTP1—Parkinson's disease	1.13e-05	9.66e-05	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—MAOA—Parkinson's disease	1.13e-05	9.64e-05	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—HMOX1—Parkinson's disease	1.12e-05	9.53e-05	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—APOE—Parkinson's disease	1.07e-05	9.15e-05	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—ABCB1—Parkinson's disease	1.07e-05	9.14e-05	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—CYP2E1—Parkinson's disease	1.06e-05	9.04e-05	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—NQO1—Parkinson's disease	1.05e-05	8.94e-05	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—GSTM1—Parkinson's disease	1.04e-05	8.88e-05	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—TH—Parkinson's disease	1.03e-05	8.81e-05	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—GPX1—Parkinson's disease	9.95e-06	8.5e-05	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—CYCS—Parkinson's disease	9.9e-06	8.46e-05	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—MTHFR—Parkinson's disease	9.19e-06	7.84e-05	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—INS—Parkinson's disease	9.15e-06	7.82e-05	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—COMT—Parkinson's disease	8.77e-06	7.49e-05	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—GSTP1—Parkinson's disease	8.73e-06	7.45e-05	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—MAOA—Parkinson's disease	8.71e-06	7.44e-05	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—HMOX1—Parkinson's disease	8.61e-06	7.35e-05	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—APOE—Parkinson's disease	8.55e-06	7.3e-05	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—ABCB1—Parkinson's disease	8.26e-06	7.06e-05	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—GSTM1—Parkinson's disease	8.02e-06	6.85e-05	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—GPX1—Parkinson's disease	7.68e-06	6.56e-05	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—INS—Parkinson's disease	7.31e-06	6.24e-05	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—MTHFR—Parkinson's disease	7.09e-06	6.05e-05	CbGpPWpGaD
Pomalidomide—PTGS2—Disease—IL6—Parkinson's disease	6.74e-06	5.75e-05	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—APOE—Parkinson's disease	6.6e-06	5.64e-05	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—INS—Parkinson's disease	5.64e-06	4.82e-05	CbGpPWpGaD
